Major Drug Companies Acquire or Partner with Smaller Biotech Firms, Business and Industry Trends Analysis

The world’s largest pharmaceutical makers have been on a buying binge, acquiring smaller biotech and drug companies at extremely high prices.  This activity accelerated significantly in recent years.  The companies that were purchased tended to be highly innovative firms with outstanding new drugs, typically in the biotech sector.  In the end, the larger companies making these acquisitions may have saved money by obtaining exciting new drugs without years of investment in research and development.  At pharmaceutical makers, profits are under constant pressure because popular drugs that have made immense profits for many years eventually lose their patent protection and face…

A Representative List of Organizations that Have Used our Research and Products: